Seoul Economic Daily EnglishCodex · 实盘不做把握 3/10
北京时间·🕒 发布 15:31:36时区推断·⟳ 抓取 15:58:18·⚡ 决策 07-27 15:59:22 +1m04s·92.3 天前
爱茉莉太平洋控股与皮肤医美设备公司Higher Corporation签署战略投资合作
本次合作方向上利好爱茉莉太平洋控股(002790.KS)拓展医美与护肤结合业务,但公告未披露投资金额、收入分成、商业化时间表或订单承诺。
📄 原文Seoul Economic Daily English↗ 原文
Amorepacific Holdings Signs Investment Deal With Skin Aesthetics Device Maker Higher Corp.
Amorepacific Holdings (002790) said on the 27th that it has signed an investment agreement with Higher Corporation, a c…
不做 爱茉莉太平洋控股(002790.KS)
未披露投资金额、订单或商业化时间表,属于中长期战略合作软催化,无法量化短周期收入或利润增量,不做。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
🔎 新鲜度:最早出现 2026-07-27 · 扩散 low · price-in 风险 medium ↗
关键理由
- 本次合作方向上利好爱茉莉太平洋控股(002790.KS)拓展医美与护肤结合业务,但公告未披露投资金额、收入分成、商业化时间表或订单承诺。
- Higher Corporation为非上市医美设备公司,事件更像中长期战略合作与产品研发规划,难以形成短周期可量化业绩传导。
- 信号发生在韩国收盘后,次日若市场反应也主要取决于情绪解读而非可验证增量。
主要风险
- 合作仍处于规划和研发协同阶段,缺少金额、产品上市节奏和医院渠道转化数据,短线重定价依据不足。
- 若后续披露具体投资规模、独家渠道或已商业化产品收入贡献,需要按新事件重新评估。
原文全文
展开原文 · 1,743 字
Amorepacific Holdings (002790) said on the 27th that it has signed an investment agreement with Higher Corporation, a company specializing in skin aesthetics medical devices, to strengthen cooperation in the beauty and medical sectors.
Through the agreement, the two companies will develop next-generation beauty and medical solutions that connect professional procedures with everyday skincare. They plan to cooperate across the entire process, from product planning to research and development (R&D), distribution and marketing, by combining Higher Corporation's expertise in developing aesthetic medical devices and its experience in joint research with medical professionals with Amorepacific's skin science research and skincare technology.
Specifically, the companies will jointly pursue the development and commercialization of skin beauty products including skin boosters, cosmeceuticals and medical devices, as well as the development of post-procedure aftercare products, distribution cooperation with hospitals and clinics, and joint R&D and marketing of raw materials and ingredients. As part of the agreement, Amorepacific Holdings (002790) made a strategic investment in Higher Corporation. Based on this, the two companies plan to build a mid- to long-term cooperative relationship and expand synergies.
Lee Sang-mok, CEO of Amorepacific Holdings, said, "Since its founding, Amorepacific has presented various solutions for customers' beauty and healthy lives based on skin science research and innovative technology. Through this cooperation, we will develop next-generation beauty solutions that combine skin science and medical device technology, and provide new customer experiences in the global beauty and medical market."
Through the agreement, the two companies will develop next-generation beauty and medical solutions that connect professional procedures with everyday skincare. They plan to cooperate across the entire process, from product planning to research and development (R&D), distribution and marketing, by combining Higher Corporation's expertise in developing aesthetic medical devices and its experience in joint research with medical professionals with Amorepacific's skin science research and skincare technology.
Specifically, the companies will jointly pursue the development and commercialization of skin beauty products including skin boosters, cosmeceuticals and medical devices, as well as the development of post-procedure aftercare products, distribution cooperation with hospitals and clinics, and joint R&D and marketing of raw materials and ingredients. As part of the agreement, Amorepacific Holdings (002790) made a strategic investment in Higher Corporation. Based on this, the two companies plan to build a mid- to long-term cooperative relationship and expand synergies.
Lee Sang-mok, CEO of Amorepacific Holdings, said, "Since its founding, Amorepacific has presented various solutions for customers' beauty and healthy lives based on skin science research and innovative technology. Through this cooperation, we will develop next-generation beauty solutions that combine skin science and medical device technology, and provide new customer experiences in the global beauty and medical market."
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。